Resolvin E1 is a novel anti-inflammatory and anti-fibrotic lipid mediator for the treatment of chronic kidney desease.

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1031/12/12

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD499,250.00
  • National Health and Medical Research Council (NHMRC) (Australia): AUD99,850.00